30 results · Page 1 of 2

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell CarcinomaHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, otorhinolaryngologic disease, squamous cell carcinomaRecruitingPhase 32026-10-08NCT07768189
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorderRecruitingPhase 2 / Phase 32026-09-30NCT06635148
Dietary Tracking in Heart Failurecardiovascular disorder, heart disorder, heart failureNot yet recruitingNot stated2026-09-28NCT07649148
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian CancerAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderActive, not recruitingPhase 32026-09-28NCT06619236
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 32026-09-25NCT05552222
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathyRecruitingPhase 2 / Phase 32026-09-25NCT05327114
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) SeizuresNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsyActive, not recruitingPhase 32026-09-09NCT05067634
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated CardiomyopathyCardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, heart valve disorder, hereditary disease, hypertrophic cardiomyopathy, laminopathy, restrictive cardiomyopathy, subvalvular aortic stenosisActive, not recruitingNot stated2026-09-02NCT05112237
Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse PopulationsNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast carcinoma, breast disorder, breast neoplasm, neoplasm, skin disorderNot yet recruitingNot stated2026-08-28NCT06926530
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)B-cell neoplasm, B-cell non-Hodgkin lymphoma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 12026-07-17NCT04970901
Cardiovascular and Metabolic Sciences BiorepositoryNutritional and Metabolic Diseases, cardiovascular disorder, metabolic diseaseRecruitingNot stated2026-06-25NCT06560424
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, leiomyosarcoma, myomatous neoplasm, neoplasm, sarcomaActive, not recruitingPhase 32026-06-18NCT06088290
Glycemic Control, Type II Diabetes, ParathyroidectomyNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperparathyroidism, metabolic disease, parathyroid gland disorder, primary hyperparathyroidism, type 2 diabetes mellitusActive, not recruitingNot stated2026-05-26NCT05761743
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)Secondary Hemophagocytic Lymphohistiocytosis (sHLH)RecruitingPhase 2 / Phase 32026-05-26NCT05416307
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)Noonan syndrome 5, low grade gliomaActive, not recruitingPhase 32026-05-14NCT05566795
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorderEnrolling by invitationNot stated2026-05-12NCT06315023
Rotator Cuff Failure With ContinuityRotator Cuff Injuries, Rotator Cuff Tears, Rupture, Shoulder Injuries, Tendon Injuries, injuryActive, not recruitingNot stated2026-05-07NCT02716441
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficienciesEnrolling by invitationPhase 32026-04-17NCT05667493
Preoperative Weight Loss for Open Abdominal Wall ReconstructionHernia, Hernia, Abdominal, Pathological Conditions, Anatomical, Pathological Conditions, Signs and SymptomsRecruitingNot applicable2026-03-23NCT05925959
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingNot stated2026-01-20NCT06401421
Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomescardiovascular disorder, hypertensive disorder, vascular disorderRecruitingNot applicable2026-01-08NCT07208669
Suture Repair vs Mesh Repair for Incisional HerniaHernia, Incisional Hernia, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative ComplicationsRecruitingNot applicable2026-01-07NCT05599750
Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal SurgeryPostoperative IleusRecruitingPhase 2 / Phase 32026-01-07NCT05334485
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver DiseaseBody Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, morbid obesity, nutritional disorder, obesity disorder, overnutritionRecruitingPhase 42025-12-23NCT07058155
Preoperative BOTOX® Injection for Large Ventral Hernia RepairHernia, Hernia, Abdominal, Hernia, Ventral, Incisional Hernia, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative ComplicationsRecruitingPhase 42025-11-21NCT07220382